While private equity investment can provide stable funding and allow practices to be innovative, it may be incompatible with physician practice ethics and sustainability, the American Medical Association wrote in a recent blog post.
Private Equity
Six private equity updates for ASCs since July 18:
Washington, D.C., Arizona and New Jersey are the top three hot spots for private equity firms acquiring physician practices, according to a study published in JAMA Health Forum.
Across six specialties, 4.9 percent of physicians worked in private equity-backed practices in 2019, according to a study published in JAMA Health Forum.
Increasing consolidation and COVID-19 have accelerated private equity's interest in ASCs.
Here are four private equity updates since July 12 that ASC leaders should keep an eye on:
MetroDerm has partnered with United Derm Partners, a private equity-backed dermatology platform and portfolio company of Frazier Healthcare Partners.
Here are five private equity updates since June 21:
Increasingly, private equity (PE) investors see physician practice management (PPM) and ASCs as attractive investment opportunities. This is because ASCs are well positioned to capitalize on some of the most important trends in healthcare, such as value-based care (VBC).
An affiliate of Capitol Pain Institute, an interventional pain management provider, and Iron Path Capital, a private equity firm, partnered to create a physician-led consolidation platform.
